Sellas Life Sciences: REGAL Study Results Due Any Day Are A Major Potential Upside Catalyst Mar 5, 2026
Iovance Biotherapeutics: Short-Term Pain, Long-Term Gain – I’m Still Bullish After All These Years Mar 4, 2026